We are live on ! Find out more
GSC

G&S Capital Portfolio holdings

AUM $345M
1-Year Est. Return 32.53%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+32.53%
3 Year Est. Return
+77.18%
5 Year Est. Return
+99.48%
10 Year Est. Return
AUM
$211M
AUM Growth
+$14.4M
Cap. Flow
-$820K
Cap. Flow %
-0.39%
Top 10 Hldgs %
30.51%
Holding
127
New
12
Increased
42
Reduced
57
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 14.7%
2 Industrials 5.43%
3 Energy 4.69%
4 Healthcare 4.25%
5 Consumer Staples 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
126
State Street Health Care Select Sector SPDR ETF
XLV
$41.6B
-16,831
Closed -$2.17M
IBTD
127
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
-9,767
Closed -$242K

Similar funds

G&S Capital's Q4 2023 Portfolio in Review

As of Q4 2023, G&S Capital held 127 positions worth $211M, up 7.3% from $196M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

G&S Capital's Q4 2023 filing shows 12 new, 42 increased, 57 reduced and 13 closed positions. Its largest new stake was FT Vest S&P 500 Dividend Aristocrats Target Income ETF: 44,561 shares worth $2.3M. The largest sale was Clorox, an estimated $2.77M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • G&S Capital's largest Q4 2023 buy was FT Vest S&P 500 Dividend Aristocrats Target Income ETF: 44,561 shares worth $2.3M.
  • G&S Capital added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2023, an estimated $5.42M increase.
  • G&S Capital's biggest Q4 2023 reduction was iShares iBonds Dec 2024 Term Treasury ETF, cutting an estimated $2.32M.
  • G&S Capital fully exited Clorox in Q4 2023, selling an estimated $2.77M.
  • G&S Capital's ten largest holdings make up 31% of its $211M portfolio in Q4 2023.
  • G&S Capital opened 12 new positions and closed 13 in Q4 2023.
  • G&S Capital's portfolio value rose 7.3% quarter-over-quarter to $211M.

Based on G&S Capital's 13F filing for Q4 2023, filed 29 Jan 2024.